Skip to content
Stock screener

MLAB Mesa Laboratories Inc stock chart & analysis

Conviction 53IndustrialsScan · Fri, Nov 6, 2026

Mesa Laboratories Inc (MLAB) closed at $128.25 (+7.50%) on Nov 6, 2026. Price is below its 50-day and above its 200-day moving average. RSI(14) 51, RS Rating 96, -11.1% from its 52-week high, +63.5% year to date. Sector: Industrials · Industrial Instruments for Measurement, Display, and Control.

MLAB$128.25+7.50%
ResistanceSupportVol 14Insider buyInsider sell
Loading chart…
Mesa Laboratories IncIndustrial Instruments for Measurement, Display, and Controlwww.mesalabs.com ↗
Price128.25
Change+7.50%
Gap+2.10%
Rel volume0.40×
Avg volume89.53K
Avg $ vol11.35M
SMA 20127.00
SMA 50128.30
SMA 200105.12
Price vs 50+0.02%
Price vs 200+22.07%
MA stackbullish
50/200 cross—
Supertrenddown · 137.90
RSI (14)51
MACD hist-0.52
MACD crossbear · 4d
Stoch %K / %D63 / 36
ADX (14)18
+DI / −DI21 / 27
RSI divergence—
MACD divergence—
ATR %4.35%
ADR %3.73%
52w high144.35
52w low69.51
From 52w high-11.10%
Above 52w low+84.61%
New 52w highNo
SqueezeOn · 5d
Bollinger width10.22%
%B0.60
Donchian pos63.00%
Donchian high134.38
Donchian low118.01
AVWAP (52w high)127.87
vs AVWAP high+0.35%
AVWAP (52w low)100.00
vs AVWAP low+28.32%
OBV trendFlat
Chaikin MF (20)-0.22
Today vs 20d0.40×
Avg vol (14d)89.1K
Avg vol (20d)89.53K
Avg $ vol (20d)11.35M
Market cap718.06M
RS Rating96 / 99
RS 3m (vs SPY)+31.14%
RS 6m (vs SPY)+22.92%
RS line new highNo
Trend template8/8
Technical rank84.0
1 week+0.40%
1 month+1.79%
3 months+26.27%
6 months+22.62%
1 year+72.94%
YTD+63.46%
P/E106.98
P/B3.80
P/S2.88
P/FCF18.14
EPS1.21
Div yield0.49%
ROE3.56%
ROA1.60%
Debt/Eq0.36
Current1.79
EV/EBITDA—
Gross margin63.53%
Net margin2.69%
Rev growth3.38%
EPS growth440.02%
Price target—
Target upside—
Analyst rating—
Institutional101.60%
Ent. value755.71M
Revenue60.14M
Net income2.83M
Gross profit39.01M
Free cash flow39.58M
IndustryIndustrial Instruments for Measurement, Display, and Control
ExchangeNasdaq
Shares out5.52M
Employees717
ListedWed, Feb 29, 1984
Free float5.05M
Float %91.4%
Short interest—
Days to cover—
Short volume44.3%
Squeeze score—
Next earningsNov 9 · after (3d)
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction53 / 100
Pattern quality—
Tech rank84.0 / 100
Group rank32 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance141.51
Support121.75
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

MLAB technical analysis

Trend

MLAB is in an uptrend: price is above the 50-day, which is above the 200-day moving average. It closed 0.0% above the 50-day ($128.30) and 22.1% above the 200-day ($105.12). ADX(14) at 18 points to a weak trend — more range than direction. It meets 8 of 8 trend-template criteria.

Momentum

RSI(14) is 51, in the bullish half of its range. MACD crossed below its signal line 4 sessions ago. Its RS Rating of 96 puts its weighted 12-month performance ahead of about 96% of the US market.

Volume and volatility

Volume on the latest session ran 0.4× its 20-day average. It trades about $11.3M a day on average. ATR(14) is $5.58, 4.3% of price — its typical daily range. Bollinger Bands are in a squeeze (5 sessions) — volatility is compressed. Chaikin Money Flow (-0.22) shows distribution.

Key levels

The chart pattern's support is $121.75 and its resistance $141.51. The 52-week range is $69.51 to $144.35; price is 11.1% below the high and 84.6% above the low. The VWAP anchored at the 52-week high is $127.87, below price.

Performance

MLAB returned +0.4% (1 week), +1.8% (1 month), +26.3% (3 months), +22.6% (6 months), +72.9% (1 year), +63.5% (year to date).

About Mesa Laboratories Inc

Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.

Industrial Instruments for Measurement, Display, and Control · Listed 1984 · 717 employees

Insider activity

SEC Form 4 transactions in MLAB

InsiderSideShares
Sullivan John James
Director · Common Stock · 2026-10-13
Gift1.2K
Hall Shannon
Director · Restricted Stock Units - 9 · 2026-09-09
Grant1.77K
Capone Mark Christopher
Director · Restricted Stock Units - 4 · 2026-09-09
Grant2.42K
Tripeny R Tony
Director · Restricted Stock Units - 5 · 2026-09-09
Grant1.77K
Sullivan John James
Director · Restricted Stock Units - 11 · 2026-09-09
Grant1.77K
Ladiwala Shiraz Shabanali
Director · Restricted Stock Units - 7 · 2026-09-09
Grant2.51K
Alltoft Jennifer Sadie
Director · Restricted Stock Units - 10 · 2009-09-09
Grant1.77K
Ladiwala Shiraz Shabanali
Director · Common Stock · 2026-08-15
Exercise3.81K
Alltoft Jennifer Sadie
Director · Common Stock · 2026-08-15
Exercise2.78K
Alltoft Jennifer Sadie
Director · Restricted Stock Units - 9 · 2026-08-15
Exercise2.78K

SEC filings

EDGAR filings in MLAB · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.

Start free — 7-day trial, no card →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.